Evidence map›Paper›PMID 35886006›Full record

ArticleGenes2022

Matthias Christen, Stefan Rupp, Iris Van Soens, Sofie F M Bhatti, Kaspar Matiasek, Thilo von Klopmann, Vidhya Jagannathan, Indiana Madden, Kevin Batcher, Danika Bannasch and 1 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Genes · 2025
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 5 countries.

Matthias ChristenInstitute of Genetics, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland.ORCID 0000-0003-3275-5929
Stefan RuppNeurology Department, Tierklinik Hofheim GbR, 65719 Hofheim am Taunus, Germany.
Iris Van SoensCompanion Animal Internal Medicine Section, Faculty of Veterinary Medicine, Liège University, 4000 Liège, Belgium.
Sofie F M BhattiSmall Animal Department, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.ORCID 0000-0002-3590-8348
Kaspar MatiasekSection of Clinical and Comparative Neuropathology, Centre for Clinical Veterinary Medicine, Ludwig-Maximilians Universität München, 80539 Munich, Germany.
Thilo von KlopmannNeurology Department, Tierklinik Hofheim GbR, 65719 Hofheim am Taunus, Germany.
Vidhya JagannathanInstitute of Genetics, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland.ORCID 0000-0002-8155-0041
Indiana MaddenDepartment of Population Health and Reproduction, University of California-Davis, Davis, CA 95616, USA.
Kevin BatcherDepartment of Population Health and Reproduction, University of California-Davis, Davis, CA 95616, USA.ORCID 0000-0002-1048-1130
Danika BannaschDepartment of Population Health and Reproduction, University of California-Davis, Davis, CA 95616, USA.ORCID 0000-0002-7614-7207
Tosso LeebInstitute of Genetics, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland.ORCID 0000-0003-0553-4880
University of Bern · CHUniversity of California, Davis · USUniversity of Hohenheim · DEGhent University · BELudwig-Maximilians-Universität München · DEUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated two litters of distantly related Nova Scotia Duck Tolling Retrievers (NSDTR), of which four puppies were affected by cerebellar signs with or without neuromuscular weakness. The phenotype was termed cerebellar degeneration—myositis complex (CDMC). We suspected a heritable condition and initiated a genetic analysis. The genome of one affected dog was sequenced and compared to 565 control genomes. This search yielded a private protein-changing SLC25A12 variant in the affected dog, XM_038584842.1:c.1337C>T, predicted to result in the amino acid change XP_038440770.1:(p.Pro446Leu). The genotypes at the variant co-segregated with the phenotype as expected for a monogenic autosomal recessive mode of inheritance in both litters. Genotyping of 533 additional NSDTR revealed variant allele frequencies of 3.6% and 1.3% in a European and a North American cohort, respectively. The available clinical and biochemical data, together with current knowledge about SLC25A12 variants and their functional impact in humans, mice, and dogs, suggest the p.Pro446Leu variant is a candidate causative defect for the observed phenotype in the affected dogs.

Indexed as

Dog DiseasesMyositisAnimalsDogsGenetic TestingGenotypeHumansMiceMitochondrial Membrane Transport ProteinsNova ScotiaMitochondrial Membrane Transport ProteinsSLC25A12 protein, humanSlc25a12 protein, mouseanimal modelaralarCanis lupus familiarisN-acetyl aspartic acidneurologyprecision medicineseizure

Identifiers

PMID35886006
PMCPMC9319113
OpenAlexW4285014418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.